Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07048392 · ClinicalTrials.gov registry record · NA

Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II

A NA study of Language Development and Specific Language Impairment, sponsored by Purdue University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT07048392: Recruiting NA study of Language Development and Specific Language Impairment, sponsored by Purdue University.

NCT07048392 is a NA study of Language Development and Specific Language Impairment that is actively recruiting participants, run by Purdue University. The registered enrollment target is 32 participants, below the 105-participant average among 13 other Language Development trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07048392, a NA study of Language Development and Specific Language Impairment, is actively recruiting participants, sponsored by Purdue University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic well-being. Word learning is one of the principal weaknesses in these children. This project focuses on the word learning abilities of four- and five-year-old children with DLD. The goal of the project is to build on the investigators' previous work to determine whether, as has been found thus far, special benefits accrue when these children must frequently recall newly introduced words during the course of learning. In this study, the investigators seek to replicate the advantage that repeated retrieval holds over simple exposure to the words appearing in the context of a story book by increasing the degree to which the words are integrated into the story line.

Primary Outcome

Child is asked to recall and say the word associated with each novel referent.

Interventions

  • BEHAVIORAL Retrieval-based word learning: Repeated Spaced Retrieval condition
  • BEHAVIORAL Retrieval-based word learning: Repeated Study condition

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-03-01
Est. Completion 2026-07-31
Phase NA
Purdue University

141 total trials

What NCT07048392 shows while recruiting

NCT07048392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 105-participant average among 13 other Language Development trials with a reported enrollment target (70% lower).

The record links to 3 conditions, with Language Development appearing as the primary indexed condition, and to 2 interventions - of which Retrieval-based word learning: Repeated Spaced Retrieval condition is the first listed.

NCT07048392 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07048392 about?

NCT07048392 is a clinical study titled "Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II". Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic well-being. Word learning is one of the principal weak...

What is the current status of trial NCT07048392?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-03-01. Estimated completion is 2026-07-31.

What conditions does trial NCT07048392 study?

This clinical trial studies the following conditions: Language Development, Specific Language Impairment, Developmental Language Disorder and Language Impairment.

What interventions are being tested in trial NCT07048392?

The interventions under investigation include: Retrieval-based word learning: Repeated Spaced Retrieval condition (BEHAVIORAL), Retrieval-based word learning: Repeated Study condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT07048392?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07048392 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Language Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07048392's enrollment target sits among peer trials

32 11th of 13 higher than 2 of 13 other Language Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Language Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07048392, the US trial registry maintained by the National Library of Medicine. NCT07048392 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.